Duncan McHale - Feb 7, 2023 Form 4 Insider Report for Evelo Biosciences, Inc. (EVLO)

Role
Chief Medical Officer
Signature
/s/ Dominic V. Capasso, Attorney-in-Fact for Duncan McHale
Stock symbol
EVLO
Transactions as of
Feb 7, 2023
Transactions value $
$0
Form type
4
Date filed
2/9/2023, 03:28 PM
Previous filing
May 31, 2022
Next filing
May 9, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVLO Restricted Stock Units Award $0 +520K $0.00 520K Feb 7, 2023 Common Stock 520K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Restricted Stock Units vest in four (4) substantially equal quarterly installments following the February 07, 2023 grant date, such that all of the Restricted Stock Units will become vested on the first anniversary of the grant date, subject to the reporting person's continued service to the issuer on each such vesting date.